IBM (NYSE: IBM) announced today that it will sell healthcare data and analytics assets from its Watson Health business to Francisco Partners. Financial terms were not disclosed for the deal, expected to close in the second quarter of this year subject to customary regulatory clearances. But Bloomberg cites people familiar with the plans saying that […]
IBM Watson
Report: IBM’s Watson for Oncology not living up to “lofty expectations”
UPDATE: Updated to indicate that IBM’s Watson for Oncology is not trying to find a cure for cancer, only treatments. After 3 years on the market, IBM’s Watson for Oncology is not living up to the hype it’s been sold under in its battle to find the best treatment for cancer, according to a new […]
Broad Institute, IBM Watson launch initiative to study cancer drug resistance
IBM Watson Health (NYSE:IBM) and the Broad Institute said today that they’ve launched a research initiative with the hopes of discovering the basis for cancer drug resistance. The 5 year, $50 million collaboration will study the genetic information of thousands of drug resistant tumors and use Watson’s machine learning methods to help understand the underlying […]
What it’s like to be a woman in the corner office: A DeviceTalks podcast
There’s an old saying that Ginger Rogers did everything Fred Astaire did, except she did it backwards and in high heels. For Nancy Briefs, Deborah DiSanzo and Martha Shadan, that’s a reality they know all too well, having each made the journey from the entry-level ranks of the medtech industry to the corner office of […]
